한글목차

개요

역형성 갑상선암 치료제 시장은 2023-2028년간 3억 70만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 6.41%를 나타낼 것으로 예측됩니다.

역형성 갑상선암 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다.갑상선암의 높은 유병률, 표적치료 도입, 노년 인구 증가가 시장 성장을 촉진하고 있습니다.

본 조사에서는 향후 몇 년간 역형성 갑상선암 치료제 시장 성장을 가속하는 주요인 중 하나로서 갑상선암에 대한 의식 고양을 들고 있습니다. 또한 역형성 갑상선암 치료의 강력한 파이프라인과 화학요법에 대한 유리한 상환 정책이 시장의 높은 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 역형성 갑상선암 치료제 시장(2018-2022년)
• 최종사용자별 부문 분석(2018-2022년)
• 제품별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원 : 시장 규모와 예측(2023-2028년)
• 클리닉 : 시장 규모와 예측(2023-2028년)
• 기타 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 최종사용자별

제7장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 화학요법 : 시장 규모와 예측(2023-2028년)
• 신규 요법 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 제품별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 이탈리아 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 캐나다 : 시장 규모와 예측(2023-2028년)
• 인도 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Bayer AG
• Bristol Myers Squibb Co.
• Daiichi Sankyo Co. Ltd.
• Eisai Co. Ltd.
• Exelixis Inc.
• Merck KGaA
• Novartis AG
• Verastem Inc.

제13장 부록

영문목차

Abstract

The anaplastic thyroid cancer drugs market is forecasted to grow by USD 300.7 mn during 2023-2028, accelerating at a CAGR of 6.41% during the forecast period. The report on the anaplastic thyroid cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of thyroid cancer, introduction of targeted therapies, and rising geriatric population.

Technavio's anaplastic thyroid cancer drugs market is segmented as below:

By End-user

• Hospitals
• Clinics
• Others

By Product

• Chemotherapy
• Novel therapy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing awareness of thyroid cancer as one of the prime reasons driving the anaplastic thyroid cancer drugs market growth during the next few years. Also, strong pipeline in the treatment of anaplastic thyroid cancer and favorable reimbursement policies for chemotherapy will lead to sizable demand in the market.

The report on the anaplastic thyroid cancer drugs market covers the following areas:

• Anaplastic thyroid cancer drugs market sizing
• Anaplastic thyroid cancer drugs market forecast
• Anaplastic thyroid cancer drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anaplastic thyroid cancer drugs market vendors that include Bayer AG, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Exelixis Inc., Merck KGaA, Novartis AG, and Verastem Inc.. Also, the anaplastic thyroid cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global anaplastic thyroid cancer drugs market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global anaplastic thyroid cancer drugs market 2018 - 2022 ($ million)
• 4.2 End-user Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - product Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Hospitals - Market size and forecast 2023-2028
• Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 6.4 Clinics - Market size and forecast 2023-2028
• Exhibit 38: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
• 6.5 Others - Market size and forecast 2023-2028
• Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ million)
• Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Chemotherapy - Market size and forecast 2023-2028
• Exhibit 52: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
• 7.4 Novel therapy - Market size and forecast 2023-2028
• Exhibit 56: Chart on Novel therapy - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Novel therapy - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Novel therapy - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Novel therapy - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ million)
• Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Italy - Market size and forecast 2023-2028
• Exhibit 87: Chart on Italy - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Italy - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Italy - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 Canada - Market size and forecast 2023-2028
• Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.11 India - Market size and forecast 2023-2028
• Exhibit 99: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Bayer AG
• Exhibit 111: Bayer AG - Overview
• Exhibit 112: Bayer AG - Business segments
• Exhibit 113: Bayer AG - Key news
• Exhibit 114: Bayer AG - Key offerings
• Exhibit 115: Bayer AG - Segment focus
• 12.4 Bristol Myers Squibb Co.
• Exhibit 116: Bristol Myers Squibb Co. - Overview
• Exhibit 117: Bristol Myers Squibb Co. - Product / Service
• Exhibit 118: Bristol Myers Squibb Co. - Key news
• Exhibit 119: Bristol Myers Squibb Co. - Key offerings
• 12.5 Daiichi Sankyo Co. Ltd.
• Exhibit 120: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 121: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibit 122: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 123: Daiichi Sankyo Co. Ltd. - Key offerings
• 12.6 Eisai Co. Ltd.
• Exhibit 124: Eisai Co. Ltd. - Overview
• Exhibit 125: Eisai Co. Ltd. - Business segments
• Exhibit 126: Eisai Co. Ltd. - Key offerings
• Exhibit 127: Eisai Co. Ltd. - Segment focus
• 12.7 Exelixis Inc.
• Exhibit 128: Exelixis Inc. - Overview
• Exhibit 129: Exelixis Inc. - Product / Service
• Exhibit 130: Exelixis Inc. - Key offerings
• 12.8 Merck KGaA
• Exhibit 131: Merck KGaA - Overview
• Exhibit 132: Merck KGaA - Business segments
• Exhibit 133: Merck KGaA - Key news
• Exhibit 134: Merck KGaA - Key offerings
• Exhibit 135: Merck KGaA - Segment focus
• 12.9 Novartis AG
• Exhibit 136: Novartis AG - Overview
• Exhibit 137: Novartis AG - Business segments
• Exhibit 138: Novartis AG - Key offerings
• Exhibit 139: Novartis AG - Segment focus
• 12.10 Verastem Inc.
• Exhibit 140: Verastem Inc. - Overview
• Exhibit 141: Verastem Inc. - Product / Service
• Exhibit 142: Verastem Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 143: Inclusions checklist
• Exhibit 144: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 145: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 146: Research methodology
• Exhibit 147: Validation techniques employed for market sizing
• Exhibit 148: Information sources
• 13.5 List of abbreviations
• Exhibit 149: List of abbreviations